Companies Like Pfizer Inc (PFE) are Boosting the Cannabis Light Market
Pfizer Inc.
Posts Tagged ‘NYSE:PFE’
10 Best Non-Tech Stocks to Buy and Hold For 3 Years
On July 4, Scott Bessent, US Treasury Secretary, gave a statement noting that the market resilience has shown that the tariffs haven’t hurt the economy.
Pfizer Advances HYMPAVZI After Successful Hemophilia Trial Results
Pfizer Inc. (NYSE:PFE) ranks among the best set-it-and-forget-it stocks to buy. On June 26, Pfizer Inc.
15 Set-It-and-Forget-It Stocks to Buy According to Analysts
As expectations for trade agreements and potential rate cuts reduced investor anxiety, the S&P 500 and Nasdaq reached record closing highs on June 30, concluding their strongest...
Pfizer’s HYMPAVZI Shows Superiority in Hemophilia A/B with Inhibitors in Phase 3 Study
Pfizer Inc. (NYSE:PFE) is one of the undervalued S&P 500 stocks to buy according to hedge funds.
10 Undervalued S&P 500 Stocks to Buy According to Hedge Funds
On June 24, Paul Hickey, Bespoke Investment Group co-founder, joined 'Squawk Box' on CNBC to suggest that periods of widespread fear often present good buying opportunities.
Pfizer’s Dividend Backed by Strong Free Cash Flow
The company’s strategy focuses on steadily increasing its dividend, reinvesting in the business with strong financial returns, and carrying out value-driven share buybacks.
10 Best Dividend Leaders to Buy Now
Investors have long favored dividend stocks for their financial strength and solid returns, which have historically outpaced many other asset classes.
Cantor Fitzgerald Maintains PFE At Neutral Amid Vaccine Guidance Changes and Regulatory Challenges
Pfizer Inc. (NYSE:PFE) is one of the 15 best stocks to invest in for an 18 year old. On June 10, Cantor Fitzgerald reaffirmed its $24 price target on Pfizer Inc.
Goldman Sachs Maintains a Hold Rating on Pfizer (NYSE:PFE), Retains $27 PT
Pfizer Inc. (NYSE:PFE) is one of the 11 Best Drug Stocks to Buy According to Hedge Funds. Analyst Asad Haider of Goldman Sachs maintained a Hold rating on Pfizer Inc.
11 Best Drug Stocks to Buy According to Hedge Funds
Health and Human Services Secretary Robert F. Kennedy Jr.
15 Best Stocks to Invest in for an 18 Year Old
The Bureau of Labor Statistics stated on June 11 that consumer prices increased less than anticipated in May given that President Donald Trump's tariffs had not yet had a noticeable...
Pfizer CEO Mentioned No Drug Price Commitments by Pfizer Inc. (PFE)
Pfizer Inc. (NYSE:PFE) is one of the best wide moat stocks to buy now.
10 Best Wide Moat Stocks To Buy Now
A wide-moat stock is a company stock that maintains market leadership through a premium product, brand value, or corporate strategy.
Was Jim Cramer Right About Pfizer Inc. (PFE)?
We recently published a list of Was Jim Cramer Right About These 9 Stocks? In this article, we are going to take a look at where Pfizer Inc.
Was Jim Cramer Right About These 9 Stocks?
During the most recent episode of Mad Money, Jim Cramer opened the show by emphasizing just how much American companies depend on China, during a time when the U.S.
Bristol-Myers (BMY) Licenses BioNTech’s Immunotherapy in $11 billion Deal
On Monday, June 2, Bloomberg reported that Bristol-Myers Squibb Company (NYSE:BMY) and BioNTech SE (NASDAQ:BNTX) announced a strategic licensing agreement focused on next-generation...
Jim Cramer Says “We Can Own The Stock of Pfizer (PFE)”
We recently published a list of Jim Cramer Recently Discussed These 15 Stocks. In this article, we are going to take a look at where Pfizer Inc.
Jim Cramer Recently Discussed These 15 Stocks
During the most recent episode of Mad Money, Jim Cramer shared his thoughts on several key events, including a wave of upcoming Q1 2025 earnings and, more critically, Friday’...
Pfizer Reports Positive Results in Late Stage Trial for Colorectal Cancer Treatment
A new drug combination has been shown to double survival time for patients with a particularly aggressive type of colorectal cancer, according to results from a late-stage clinical...
Was Jim Cramer Right About Pfizer Inc. (PFE)?
We recently published a list of Was Jim Cramer Right About These 12 Stocks? In this article, we are going to take a look at where Pfizer Inc.
Was Jim Cramer Right About These 12 Stocks?
During the most recent episode of Mad Money, which aired on Friday, May 16th, Jim Cramer highlighted a sharp turnaround in market sentiment, noting how investors shifted from ...
Citi Maintains a Hold Rating on Pfizer (PFE) Amidst Pricing Policy Headwinds
On May 21, analyst Geoff Meacham of Citi maintained a Hold rating on Pfizer Inc. (NYSE:PFE), reiterating the price target of $25.
Bernstein Reaffirms Pfizer Rating After $6B Cancer Treatment Deal
Bernstein analysts reaffirmed their Market Perform rating and $30 price target for Pfizer Inc.
BMO Capital Maintains Buy Rating on Pfizer (PFE) Stock
On May 20, BMO Capital analyst Evan Seigerman maintained a Buy rating on Pfizer Inc. (NYSE:PFE) and kept the price target the same at $30.
Pfizer Inc. (PFE) Inks $6 Billion Cancer Drug Licensing Agreement with China’s 3SBio
On May 19, Pfizer Inc. (NYSE:PFE) announced it had entered into a licensing agreement valued at approximately $6 billion with Chinese biopharmaceutical firm 3SBio Inc.
13 Best Cheap Stocks to Invest in for Beginners
The last time the S&P erased a 15% decline in under six weeks was 1982, which tells a lot about the current market dynamics we are currently in.
13 Stocks on Jim Cramer’s Radar Recently
On Monday's episode of Mad Money, Jim Cramer broke down the day’s market rally and argued in favor of staying invested, even in times of uncertainty.
13 Best High Volume Stocks to Buy Now
On May 9, BMO private wealth chief market strategist Carol Schleif joined CNBC's 'Squawk Box' to discuss the latest market trends and the state of the economy.
Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now
Domestic manufacturing in the pharmaceutical industry has fallen considerably in the last decades, with most active ingredient production moving to China and other countries.
15 Best High-Yield Dividend Stocks for 2025 and Beyond
Over the years, dividend-paying stocks have become increasingly popular as investors lean toward income-focused investment strategies.
13 Stock Predictions That Jim Cramer Got Completely Wrong
During a recent episode of Mad Money, which aired on Monday, the 5th of May, Jim Cramer gave some personal anecdotes from his experience as an investor.
Jim Cramer Reveals Trump’s Potential Secret Weapon In China Trade Talks & Discusses These 10 Stocks
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer discussed the impacts that tariffs have had on businesses.
10 Most Profitable Cheap Stocks to Buy Now
US stocks rose on Friday, May 2, as the S&P 500, Dow Jones Industrial Average, and the tech-heavy Nasdaq all posted impressive gains.
Pfizer Inc. (NYSE:PFE) Q1 2025 Earnings Call Transcript
Operator: Good day, everyone. And welcome to Pfizer Inc.'s First Quarter 2025 Earnings Conference Call. Today's call is being recorded.
Billionaire Ken Fisher’s 10 Healthcare Stock Picks with Massive Upside Potential
The healthcare industry, an essential component of global well-being and economic resilience, is undergoing significant changes.
Jim Cramer’s Thoughts on These 5 Stocks
“President Trump, what took you so long? This man went almost a hundred days before he finally said he'd like to see Fed Chief Jay Powell ousted for keeping interest rates too...
15 Recent Activist Investor Campaigns
Economic uncertainty and market volatility are some of the factors fueling activist investor campaigns in 2025.
10 Safe Dividend Stocks with Yields Above 5%
Dividend-paying stocks have long held a special place among investors, often delivering stronger returns than the broader market over time.
Jeff Smith’s Top 10 Activist Targets and Their Returns Compared to the S&P 500
Jeff Smith is arguably the “most feared man” in corporate America, having waged some of Wall Street's most aggressive and successful activist campaigns.
15 Best Large-Cap Value Stocks to Buy as the Recession Hits
Goldman Sachs highlighted that equities around the world traded in and out of a bear market — which is often defined as a 20% decline from the recent peak.
10 Stocks on Jim Cramer’s Radar
On Thursday, Mad Money host Jim Cramer cautioned viewers about what may lie ahead once the 90-day pause on new tariffs comes to an end.
11 Best Dividend Paying Stocks to Buy According to Hedge Funds
Dividend-paying stocks have consistently attracted investor interest due to their long-term value.
11 Cheap NYSE Stocks to Invest in According to Hedge Funds
On March 26, Jack Caffrey of JPMorgan Asset Management provided an analysis of market trends in a discussion on CNBC's 'Squawk Box'.
Jim Cramer Reveals How Markets Can Stabilize & Discusses These 8 Stocks
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer shared what the Trump administration could do to stop the stock market bloodbath unleashed by tariffs.
11 Best Innovative Stocks to Buy According to Analysts
Innovative stocks are the companies that continuously invest in developing new products, services or even entire business models, enabling them to stay ahead of competition and...
Jim Cramer’s Lightning Round: 8 Stocks in Focus
Jim Cramer, host of Mad Money, discussed on Monday how investor sentiment surrounding tech stocks has shifted over the past three months.
8 Most Undervalued Healthcare Stocks to Buy According to Analysts
Healthcare prices and expenditures have been rising in the United States.
